Article
Has Noninvasive Prenatal Testing Impacted Termination of Pregnancy and Live Birth Rates of Infants With Down Syndrome?
2018-05-01
Abstract excerpt
(Abstracted from Prenat Diagn 2017;37:1281–1290) Noninvasive prenatal testing (NIPT) for aneuploidy using cell-free DNA (cfDNA) has become widely available and popular for detection of Down syndrome (DS) because of its high sensitivity (99%) and specificity (99.5%). The acceptance of NIPT as an alternative to the first-trimester combined test has greatly reduced the use of invasive prenatal diagnostic testing.
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9d326961-ef12-558a-a458-5a89bce2bd2c
- DOI
- 10.1097/01.ogx.0000534154.01991.cc
